A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
[Protocol 13-045] |
Younes, Anas |
|
A Phase I Study of Dabrafenib and Ipilimumab with and without Trametinib for Advanced Melanoma
[Protocol 12-285] |
Wolchok, Jedd |
|
A Phase I Study of Dabrafenib plus Lapatinib to Treat Inoperable Thyroid Cancers with Abnormal BRAF
[Protocol 13-061] |
Sherman, Eric |
|
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083] |
Carvajal, Richard |
|
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131] |
Voss, Martin |
- Bladder Cancer
- Breast Cancer
- Endometrial and other Uterine Cancers
- Head & Neck Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
- Solid Tumors
- Upper Gastrointestinal
|
A Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155] |
Traina, Tiffany |
|
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181] |
Tallman, Martin |
- Hematology
- Hematologic Malignancies
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
|
A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
[Protocol 10-021] |
Abou-Alfa, Ghassan |
|
A Phase I Study of Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
[Protocol 13-052] |
Curran, Kevin |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138] |
Brentjens, Renier |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169] |
Rusch, Valerie |
- Breast Cancer
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
- Mesothelioma
|
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
[Protocol 04-101] |
Gilewski, Teresa |
|
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
[Protocol 12-117] |
Sauter, Craig |
|
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009] |
Basu, Ellen |
- Neuroblastoma
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116] |
Roberts, Stephen |
- Neuroblastoma
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057] |
Omuro, Antonio |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase I Study of IMGN529 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
[Protocol 13-073] |
Palomba, M. Lia |
|
A Phase I Study of IMMU-130 in Patients with Colorectal Cancer
[Protocol 11-074] |
Segal, Neil |
|
A Phase I Study of Induction Chemotherapy with Afatinib, Ribavirin, and Carboplatin/Paclitaxel in Patients with Stage IV HPV-Associated Oropharynx Cancer
[Protocol 12-150] |
Fury, Matthew |
|
